Role of bronchial artery embolization in the management of hemoptysis

Hiran C. Fernando, Moni Stein, John R. Benfield, Daniel P Link

Research output: Contribution to journalArticle

105 Citations (Scopus)

Abstract

Objective: To assess the modern morbidity of hemoptysis and the contribution of therapeutic bronchial artery embolization to its management. Methods: Medical record review of patients admitted for the treatment of hemoptysis from January 1991 to November 1995 and of patients who had therapeutic bronchial artery embolization from June 1986 to August 1995. Hemoptysis was labeled major or minor. Results: A total of 138 patients were admitted with hemoptysis, 31 with major and 107 with minor hemoptysis. No emergency pulmonary resections were required. Mean follow-up was 13.5 months. Mortality was 29.7% (41/138) but was caused by bronchial bleeding in only 4.3% (6/138). Twenty-six patients underwent therapeutic bronchial artery embolization (mean follow-up [range], 14 months [0.3-69.0 months]). The initial success rate (no further bleeding during the initial admission) was 85% (22/26). The long-term success rate (no further bleeding during follow- up) was 58% (15/26). Only 2 patients with therapeutic bronchial artery embolization died of further hemoptysis. Conclusions: Hemoptysis signals life-threatening diseases. Therapeutic bronchial artery embolization is a good treatment adjunct to control bronchial bleeding and reduces the need for high-risk emergency lung resections.

Original languageEnglish (US)
Pages (from-to)862-866
Number of pages5
JournalArchives of Surgery
Volume133
Issue number8
DOIs
StatePublished - Aug 1998

Fingerprint

Bronchial Arteries
Hemoptysis
Hemorrhage
Therapeutics
Emergencies
Lung
Medical Records
Morbidity
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Fernando, H. C., Stein, M., Benfield, J. R., & Link, D. P. (1998). Role of bronchial artery embolization in the management of hemoptysis. Archives of Surgery, 133(8), 862-866. https://doi.org/10.1001/archsurg.133.8.862

Role of bronchial artery embolization in the management of hemoptysis. / Fernando, Hiran C.; Stein, Moni; Benfield, John R.; Link, Daniel P.

In: Archives of Surgery, Vol. 133, No. 8, 08.1998, p. 862-866.

Research output: Contribution to journalArticle

Fernando, HC, Stein, M, Benfield, JR & Link, DP 1998, 'Role of bronchial artery embolization in the management of hemoptysis', Archives of Surgery, vol. 133, no. 8, pp. 862-866. https://doi.org/10.1001/archsurg.133.8.862
Fernando, Hiran C. ; Stein, Moni ; Benfield, John R. ; Link, Daniel P. / Role of bronchial artery embolization in the management of hemoptysis. In: Archives of Surgery. 1998 ; Vol. 133, No. 8. pp. 862-866.
@article{9a956b69180c4042b4f00375f5a89c36,
title = "Role of bronchial artery embolization in the management of hemoptysis",
abstract = "Objective: To assess the modern morbidity of hemoptysis and the contribution of therapeutic bronchial artery embolization to its management. Methods: Medical record review of patients admitted for the treatment of hemoptysis from January 1991 to November 1995 and of patients who had therapeutic bronchial artery embolization from June 1986 to August 1995. Hemoptysis was labeled major or minor. Results: A total of 138 patients were admitted with hemoptysis, 31 with major and 107 with minor hemoptysis. No emergency pulmonary resections were required. Mean follow-up was 13.5 months. Mortality was 29.7{\%} (41/138) but was caused by bronchial bleeding in only 4.3{\%} (6/138). Twenty-six patients underwent therapeutic bronchial artery embolization (mean follow-up [range], 14 months [0.3-69.0 months]). The initial success rate (no further bleeding during the initial admission) was 85{\%} (22/26). The long-term success rate (no further bleeding during follow- up) was 58{\%} (15/26). Only 2 patients with therapeutic bronchial artery embolization died of further hemoptysis. Conclusions: Hemoptysis signals life-threatening diseases. Therapeutic bronchial artery embolization is a good treatment adjunct to control bronchial bleeding and reduces the need for high-risk emergency lung resections.",
author = "Fernando, {Hiran C.} and Moni Stein and Benfield, {John R.} and Link, {Daniel P}",
year = "1998",
month = "8",
doi = "10.1001/archsurg.133.8.862",
language = "English (US)",
volume = "133",
pages = "862--866",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "8",

}

TY - JOUR

T1 - Role of bronchial artery embolization in the management of hemoptysis

AU - Fernando, Hiran C.

AU - Stein, Moni

AU - Benfield, John R.

AU - Link, Daniel P

PY - 1998/8

Y1 - 1998/8

N2 - Objective: To assess the modern morbidity of hemoptysis and the contribution of therapeutic bronchial artery embolization to its management. Methods: Medical record review of patients admitted for the treatment of hemoptysis from January 1991 to November 1995 and of patients who had therapeutic bronchial artery embolization from June 1986 to August 1995. Hemoptysis was labeled major or minor. Results: A total of 138 patients were admitted with hemoptysis, 31 with major and 107 with minor hemoptysis. No emergency pulmonary resections were required. Mean follow-up was 13.5 months. Mortality was 29.7% (41/138) but was caused by bronchial bleeding in only 4.3% (6/138). Twenty-six patients underwent therapeutic bronchial artery embolization (mean follow-up [range], 14 months [0.3-69.0 months]). The initial success rate (no further bleeding during the initial admission) was 85% (22/26). The long-term success rate (no further bleeding during follow- up) was 58% (15/26). Only 2 patients with therapeutic bronchial artery embolization died of further hemoptysis. Conclusions: Hemoptysis signals life-threatening diseases. Therapeutic bronchial artery embolization is a good treatment adjunct to control bronchial bleeding and reduces the need for high-risk emergency lung resections.

AB - Objective: To assess the modern morbidity of hemoptysis and the contribution of therapeutic bronchial artery embolization to its management. Methods: Medical record review of patients admitted for the treatment of hemoptysis from January 1991 to November 1995 and of patients who had therapeutic bronchial artery embolization from June 1986 to August 1995. Hemoptysis was labeled major or minor. Results: A total of 138 patients were admitted with hemoptysis, 31 with major and 107 with minor hemoptysis. No emergency pulmonary resections were required. Mean follow-up was 13.5 months. Mortality was 29.7% (41/138) but was caused by bronchial bleeding in only 4.3% (6/138). Twenty-six patients underwent therapeutic bronchial artery embolization (mean follow-up [range], 14 months [0.3-69.0 months]). The initial success rate (no further bleeding during the initial admission) was 85% (22/26). The long-term success rate (no further bleeding during follow- up) was 58% (15/26). Only 2 patients with therapeutic bronchial artery embolization died of further hemoptysis. Conclusions: Hemoptysis signals life-threatening diseases. Therapeutic bronchial artery embolization is a good treatment adjunct to control bronchial bleeding and reduces the need for high-risk emergency lung resections.

UR - http://www.scopus.com/inward/record.url?scp=0031876759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031876759&partnerID=8YFLogxK

U2 - 10.1001/archsurg.133.8.862

DO - 10.1001/archsurg.133.8.862

M3 - Article

C2 - 9711960

AN - SCOPUS:0031876759

VL - 133

SP - 862

EP - 866

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 8

ER -